Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn's Disease

• Main Authors: Qianqian Li (Author), Xiao Ding (Author), Yujie Liu (Author), Cicilia Marcella (Author), Min Dai (Author), Ting Zhang (Author), Jianling Bai (Author), Liyuan Xiang (Author), Quan Wen (Author), Bota Cui (Author), Faming Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: How to handle patients with anti-tumor necrosis factor (anti-TNF) failure was a common challenge to clinicians in Crohn's disease (CD). The present study is dedicated to clarifying whether fecal microbiota transplantation (FMT) could be a switch therapy for patients with prior failu...